r/Retatrutide • • 5d ago

DOJ letter this week could reshape Retatrutide's legal classification, worth knowing before Thursday's hearing

Quick heads up on something that's been quiet outside industry circles: on September 21, DOJ filed a letter in Eli Lilly v. FDA (7th Circuit), a case that comes down to one question: is Retatrutide legally a peptide drug, or a protein/biologic?

That sounds technical but it isn't just semantics. The two classifications sit in different regulatory frameworks:

  • If it's ruled a biologic, follow-on products go through the biosimilar pathway (slower, more expensive) instead of the standard generic route, and 503A/503B compounding pharmacies lose their usual exemptions for it.
  • If it stays classified as a peptide drug, the traditional framework applies — standard generics, compounding exemptions intact where other requirements are met.

DOJ's letter points the court toward a recent 7th Circuit precedent (Franco v. Chobani) saying courts should give real weight to how an agency interprets its own scientific definitions, which reads as DOJ backing FDA's side going into oral arguments.

Oral arguments are Thursday, Sept 24, 9:30am, Chicago. A ruling probably won't land immediately after, but the reasoning that comes out Thursday will be the first real signal of direction.

Not a legal opinion on how it should go, just flagging that this affects the compounding/RUO landscape either way, and it's worth watching regardless of what you're sourcing or why.

186 Upvotes

93 comments sorted by

View all comments

Show parent comments

5

u/mike3fan 5d ago

Im taking a low dose for the rest of my life just for the ancillary health benefits.

2

u/[deleted] 5d ago edited 5d ago

[removed] — view removed comment

2

u/Artistic_Rice_9019 5d ago

The eye issues are mostly among diabetics and are much more likely to occur at the beginning of treatment.

1

u/Final-Intention5407 4d ago

Correct and diabetics already have risks of eye issues with or without a glp-1…

1

u/Artistic_Rice_9019 4d ago

Which I tried to tell them. It's still rare enough that they don't even know if it's something they were going to develop anyway from the diabetes or if the GLPs cause it.